VANCOUVER, British Columbia, May 11, 2023 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. XENEa biopharmaceutical company specializing in neurology, today announced that it will be a presenter at the RBC Capital Markets Global Healthcare Conference 2023, taking place May 16-17, 2023 in New York, NY.
Company fireside chat presentation details:
| Date: | Tuesday, May 16, 2023 | |
| Time: | 3:05 p.m. Eastern Time / 12:05 p.m. Pacific Time | |
| web cast: | Register here | |
| Moderators: | Ian Mortimer, President and CEO Sherry Aulin, CFO |
|
A live webcast of the company’s presentation will be available on the website.investorssection of the Xenon website and posted for review after the event. The dates and times listed above are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharma XENE is a clinical-stage biopharmaceutical company dedicated to the development of innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurological therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other marks belong to their respective owners.
Investor/media contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Telephone: 604.484.3353
E-mail: investors@xenon-pharma.com
[ad_2]
Source story
